Effect of "Sekanjabin e Safarjali" (Quince Oxymel) in the Prevention of Migraine Attacks

NCT02179775 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Migraine Headache
Gastric Diseases

Interventions

DRUG: propranolol
DRUG: Quince's oxymel
DRUG: placebo

Sponsor

Shiraz University of Medical Sciences